Active Biotech
0.073
SEK
Less than 1K followers
ACTI
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
+2.8%
-29.01%
-32.54%
-38.63%
-59%
-72.02%
-83.95%
-90.24%
-98.6%
Active Biotech operates in the pharmaceutical industry and focuses on the development of innovative treatments for cancer and autoimmune diseases. The company researches new therapies that can improve patient outcomes and quality of life. The business is global with a primary presence in Europe and North America. Active Biotech was founded in 1998 and is headquartered in Lund, Sweden.
Read moreMarket cap
90.29M SEK
Turnover
-
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
8.5
2025
Interim report Q1'25
28.5
2025
General meeting '25
21.8
2025
Interim report Q2'25
All
Webcasts
Press releases
ShowingAll content types
First patient enrolled in the HO172 clinical study of tasquinimod in myelofibrosis
Redeye: Active Biotech Q4 2024 - Funded through 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools